A team of researchers from the Laboratory of Biophysics at NUST MISIS, Lomonosov Moscow State University and D. Mendeleev University of Chemical Technology of Russia has summarized metal-containing diagnostic agents for positron emission tomography (PET), magnetic resonance imaging (MRI), and single-photon emission computed tomography (SPECT) imaging of Alzheimer’s disease (AD). According to the researchers, metal-containing radiopharmaceuticals are not only highly effective for detecting early markers of Alzheimer’s disease, but also synchrotron-independent and long-lived. Thus, their use could improve access to diagnostic imaging of AD among the risk groups. The review was published in the International Journal of Molecular Sciences.
…
